SMARCA4 has been associated with MIA-related autism spectrum disorder [56], and the nuclear factor kappa B subunit 1 (NFKB1) enrichment is aligned with the low-level chronic inflammation and enhanced response to an inflammatory stimulus in a knockout mouse model [57]. Here, NFKB1 is linked to autism spectrum disorder.